SCHEMBL17802412

SCHEMBL17802412

OCC(O)C(c1ccccc1)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 9/20 0.49
SLC6A4 P31645 9/20 0.49
SLC6A3 Q01959 9/20 0.49
CYP3A4 P08684 8/20 0.49
CYP2D6 P10635 8/20 0.49
KCNH2 Q12809 6/20 0.49
HTR1A P08908 1/20 0.46
HTR7 P34969 1/20 0.46
IDO1 P14902 1/20 0.45
TDO2 P48775 1/20 0.45
IDO2 Q6ZQW0 1/20 0.45
PLA2G1B P04054 1/20 0.42
POLB P06746 1/20 0.42
ATG4B Q9Y4P1 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CYP1A2 P05177 1/20 0.41
MAPT P10636 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17802376 1.00 SLC6A2 (0.49) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL17814886 1.00 SLC6A2 (0.49) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL17802378 0.82 TSHR (0.48) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL246459 0.82 LMNA (0.44) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL301347 0.82 LMNA (0.44) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL11633139 0.81 SLC6A4 (0.66) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL477651 0.78 IDO1 (0.53) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL17802370 0.75 HTR2A (0.50) SLC6A2SLC6A4SLC6A3HTR1AMEN1
SCHEMBL17814899 0.75 HTT (0.42) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL3754107 0.74 ALDH1A1 (0.45) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016088138-A1 DIPHENYLOXIRANES, PROCESS FOR PREPARATION THEREOF, AND ITS USE IN AN ENANTIOSELECTIVE SYNTHESIS OF (+)-SERTRALINE COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-06-09 WO disclosed